Barclays Increases Church & Dwight (NYSE:CHD) Price Target to $83.00

Church & Dwight (NYSE:CHD) had its target price hoisted by investment analysts at Barclays from $80.00 to $83.00 in a report issued on Friday, Benzinga reports. The brokerage presently has an “underweight” rating on the stock. Barclays‘s price objective points to a potential downside of 17.89% from the stock’s previous close.

CHD has been the topic of a number of other reports. Oppenheimer raised their price target on shares of Church & Dwight from $107.00 to $110.00 and gave the stock an “outperform” rating in a research report on Monday, February 5th. Stifel Nicolaus raised their price target on shares of Church & Dwight from $91.00 to $99.00 and gave the stock a “hold” rating in a research report on Monday, February 5th. Argus raised shares of Church & Dwight from a “hold” rating to a “buy” rating and set a $115.00 price objective on the stock in a report on Friday, February 23rd. Royal Bank of Canada increased their price objective on shares of Church & Dwight from $94.00 to $103.00 and gave the stock a “sector perform” rating in a report on Monday, February 5th. Finally, UBS Group increased their price objective on shares of Church & Dwight from $99.00 to $105.00 and gave the stock a “neutral” rating in a report on Monday, February 5th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, Church & Dwight presently has an average rating of “Hold” and a consensus target price of $103.00.

Church & Dwight Trading Down 0.5 %

NYSE CHD opened at $101.08 on Friday. Church & Dwight has a 12 month low of $82.25 and a 12 month high of $105.67. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.08 and a quick ratio of 0.64. The company has a market capitalization of $24.65 billion, a price-to-earnings ratio of 33.25, a price-to-earnings-growth ratio of 3.49 and a beta of 0.53. The company’s fifty day moving average price is $101.69 and its two-hundred day moving average price is $96.13.

Church & Dwight (NYSE:CHD) last posted its quarterly earnings results on Friday, February 2nd. The company reported $0.65 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.65. Church & Dwight had a net margin of 12.88% and a return on equity of 20.28%. The company had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.51 billion. During the same period last year, the firm posted $0.62 EPS. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. As a group, research analysts predict that Church & Dwight will post 3.44 earnings per share for the current fiscal year.

Insider Buying and Selling at Church & Dwight

In other news, EVP Michael Read sold 4,500 shares of Church & Dwight stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $105.00, for a total value of $472,500.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, EVP Michael Read sold 4,500 shares of Church & Dwight stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $105.00, for a total value of $472,500.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Penry W. Price sold 7,752 shares of Church & Dwight stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $98.29, for a total transaction of $761,944.08. Following the completion of the transaction, the director now directly owns 25,692 shares in the company, valued at approximately $2,525,266.68. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 373,052 shares of company stock valued at $38,603,796. Company insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in CHD. Sei Investments Co. boosted its holdings in shares of Church & Dwight by 11.7% in the first quarter. Sei Investments Co. now owns 148,186 shares of the company’s stock worth $14,670,000 after buying an additional 15,509 shares during the period. Sequoia Financial Advisors LLC boosted its holdings in shares of Church & Dwight by 27.8% in the first quarter. Sequoia Financial Advisors LLC now owns 3,078 shares of the company’s stock worth $306,000 after buying an additional 670 shares during the period. Candriam Luxembourg S.C.A. boosted its holdings in shares of Church & Dwight by 226.2% in the first quarter. Candriam Luxembourg S.C.A. now owns 55,918 shares of the company’s stock worth $5,557,000 after buying an additional 38,777 shares during the period. Baird Financial Group Inc. boosted its holdings in shares of Church & Dwight by 119.2% in the first quarter. Baird Financial Group Inc. now owns 22,674 shares of the company’s stock worth $2,253,000 after buying an additional 12,328 shares during the period. Finally, Brown Brothers Harriman & Co. boosted its holdings in shares of Church & Dwight by 54.6% in the first quarter. Brown Brothers Harriman & Co. now owns 1,702 shares of the company’s stock worth $169,000 after buying an additional 601 shares during the period. 86.60% of the stock is currently owned by institutional investors and hedge funds.

About Church & Dwight

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.